Compare Multi Indocitra Tbk. (MICE) vs Charlie Hospital Semarang Tbk. (RSCH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Multi Indocitra Tbk. vs Charlie Hospital Semarang Tbk. — how do they compare? Multi Indocitra Tbk. trades at Rp530 (market cap 303B, 154.1K 24h volume), while Charlie Hospital Semarang Tbk. trades at Rp258 (market cap 678.4B, 25.57M 24h volume). The key difference: Charlie Hospital Semarang Tbk. is far larger — about 2.2× Multi Indocitra Tbk.'s market cap, and Charlie Hospital Semarang Tbk. is more actively traded (25.57M versus 154.1K). Which is the better fit depends on your goals.
| MICE | RSCH | |
|---|---|---|
Market Cap | 303B | 678.4B |
Volume | 154.1K | 25.57M |
Lot | 1.54K | 255.67K |
Turnover | 81.24M | 6.57B |
Average Price | 527.17 | 256.8 |
Value | 81.24M | 6.57B |
Indicative Equilibrium Price | — | 258 |
Indicative Equilibrium Volume | — | 110 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Multi Indocitra Tbk.
PT Multi Indocitra Tbk (the Company) was established under its original name of Modern Indocitra based on notarial deed No. 52 of Esther Daniar Iskandar, S.H dated January 11, 1990. The Company's articles of association has been amended several times, the latest amendment dated Aug 16, 2005, regarding the change in the Company's status from private company to public company.
Read more on MICE →About Charlie Hospital Semarang Tbk.
PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Read more on RSCH →
